Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A11 | P48066 | 4/20 | 0.44 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KIF11 | P52732 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.39 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8655117 | 0.89 | SLC6A11 (0.44) | SLC6A11SLC6A1KMT2AKIF11ALDH1A1 | |
| SCHEMBL7010042 | 0.88 | SLC6A11 (0.46) | SLC6A11SLC6A1KMT2AKIF11MEN1 | |
| SCHEMBL8388886 | 0.86 | SLC6A11 (0.44) | SLC6A11SLC6A1KMT2AKIF11ALDH1A1 | |
| SCHEMBL18803715 | 0.84 | KIF11 (0.52) | SLC6A11SLC6A1KMT2AKIF11KCNH2 | |
| SCHEMBL14879264 | 0.84 | KIF11 (0.52) | SLC6A11SLC6A1KMT2AKIF11KCNH2 | |
| SCHEMBL8659005 | 0.84 | SLC6A11 (0.45) | SLC6A11SLC6A1KMT2AKIF11ALDH1A1 | |
| SCHEMBL9305514 | 0.84 | SLC6A11 (0.43) | SLC6A11SLC6A1KMT2AKIF11ALDH1A1 | |
| SCHEMBL9305860 | 0.82 | SLC6A11 (0.41) | SLC6A11SLC6A1KMT2AKIF11MEN1 | |
| SCHEMBL16197752 | 0.81 | KIF11 (0.50) | SLC6A11SLC6A1KMT2AKIF11KCNH2 | |
| SCHEMBL21449652 | 0.80 | SLC6A11 (0.40) | SLC6A11SLC6A1KMT2AKIF11MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018180-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | AJINOMOTO CO., INC. (JP) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018180-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | RNGTT, NOX4, POLRMT | SLC6A11 4567/4885SLC6A1 4769/4885KMT2A 2534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.